Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Med Res Rev. 2018 May 4;38(6):1974–2023. doi: 10.1002/med.21503

Figure 15.

Figure 15

Chemical structures of macrocyclic peptidomimetic 58–63 acting as active site inhibitors of FXIa. Inhibitors’ Ki values are provided in nM. Corresponding acyclic inhibitors are imidazole-containing derivatives with P1 domain of 1-(4-chlorophenyl)-1H-tetrazole 58–61 or tranexamic acid 63.